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eterminants of Significant
aravalvular Regurgitation After
ranscatheter Aortic Valve Implantation
mpact of Device and Annulus Discongruence
elphine Détaint, MD, Laurent Lepage, MD, Dominique Himbert, MD, Eric Brochet, MD,
avid Messika-Zeitoun, MD, Bernard Iung, MD, Alec Vahanian, MD
aris, France
bjectives The aim of this study was to assess prosthesis/annulus discongruence and its impact on
he occurrence of signiﬁcant aortic regurgitation (AR) immediately after transcatheter aortic valve
mplantation (TAVI).
ackground Paravalvular AR might occur after TAVI, but its determinants remain unclear.
ethods Comprehensive echocardiographic examinations were performed in 74 patients who un-
erwent TAVI with a balloon expandable device. Congruence between annulus and device was ap-
raised with the cover index: 100  (prosthesis diameter  transesophageal echocardiography an-
ulus diameter)/prosthesis diameter.
esults At baseline aortic valve area was 0.67  0.2 cm2, and mean gradient was 50  15 mm Hg.
he TAVI used transfemoral approach in 46 patients (62%) and transapical access in 28 (38%). Pros-
hesis size was 23 mm in 24 patients (34%) and 26 mm in 50 patients (66%). After TAVI, paravalvular
R was absent in 5 patients (7%), graded 1/4 in 53 (72%), 2/4 in 12 (16%), and 3/4 in 4 (5%). Occur-
ence of AR 2/4 was related to greater patient height, larger annulus, and smaller cover index (all
 0.002) but not to ejection fraction, severity of stenosis, or prosthesis size. AR 2/4 was never
bserved in patients with aortic annulus 22 mm or with a cover index 8%. Signiﬁcant improve-
ents were observed from the ﬁrst 20 cases (AR 2/4, 40%) to the last 54 (AR 2/4, 15%) (p 
.02). In multivariate analysis, independent predictors of AR 2/4 were low cover index (odds ratio:
.22; per conﬁdence interval: 1.03 to 1.51 per 1% decrease, p  0.02) and ﬁrst versus last proce-
ures (odds ratio: 2.24; 95% conﬁdence interval: 1.07 to 5.22, p  0.03).
onclusions Our study shows that the occurrence of AR 2/4 is related to prosthesis/annulus dis-
ongruence even after adjustment for experience. Hence, to minimize paravalvular AR, appropriate
nnular measurements and prosthesis sizing are critical. (J Am Coll Cardiol Intv 2009;2:821–7)
2009 by the American College of Cardiology Foundation
rom the Cardiology Department, Hopital Bichat, Paris, France.anuscript received April 7, 2009; revised manuscript received June 29, 2009, accepted July 28, 2009.
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822ver the last few years the transcatheter aortic valve
mplantation (TAVI) technique has been developed (1–4)
s an alternative to surgical aortic valve replacement for
evere aortic stenosis in patients with high surgical risk or
ontraindications to surgery (5–9). The evidence that is
urrently available suggests that this technique is feasible
nd provides hemodynamic and clinical improvement up to
years, but questions remain concerning safety and long-
erm durability (10). Regarding safety, the occurrence of
ignificant aortic regurgitation (AR) after TAVI was ini-
ially described as a limitation of this technique (2,3).
espite improvements, significant AR can still occur, and
ts determinants have not been specifically studied so far.
hus, we examined in this study the determinants of
ignificant AR occurring immediately after TAVI.
ethods
atient characteristics. Between October 2006 and Decem-
er 2008, 74 consecutive patients underwent a TAVI
rocedure with successful prosthesis implantation.
TAVI. Procedures were performed
by the transfemoral approach
(4,5,8) or by the transapical ap-
proach when femoroiliac axes were
not suitable, as previously described
(11–14).
In brief, after crossing of the
aortic valve and balloon valvu-
loplasty, a balloon expandable
valve (Edwards-Sapien, Ed-
wards Lifesciences, Inc., Irvine,
California) was pushed by a flex-
ble catheter and positioned within the native aortic annu-
us. The delivery balloon was inflated, and the valved stent
as implanted. The device is available in 2 sizes: 23 and 26
m. A 23-mm device was implanted when the diameter of
he aortic annulus was 18 and 21 mm, and a 26-mm
evice was implanted when the diameter of the aortic
nnulus was 21 and 25 mm.
To account for the potential learning curve, we defined 2
ime periods—from October 9, 2006, to January 9, 2008, for
he 20 first procedures (early period) and from January 16,
008, to December 23, 2008, for the last 54 procedures (late
eriod).
chocardiography. ECHOCARDIOGRAPHIC EXAMINATIONS
EFORE TAVI. All the patients underwent a comprehensive
ransthoracic echocardiography (TTE) at baseline. The
everity of aortic stenosis was assessed by the aortic mean
radient and aortic valve area (AVA), which was calculated
ith the continuity equation (15). Measurements of the
ortic annulus were performed in systole in a parasternal
ong-axis view, zoomed on the left ventricular outflow tract,
bbreviations and
cronyms
R  aortic regurgitation
VA  aortic valve area
AVI  transcatheter aortic
alve implantation
EE  transesophageal
chocardiography
TE  transthoracic
chocardiographyt the point of insertion of the aortic cusps. Ejection fraction las calculated with left ventricular volumes, obtained by the
-dimensional echocardiographic biplane Simpson’s rule
16). Aortic regurgitation was evaluated according to pub-
ished guidelines (17–19).
All the patients underwent a transesophageal echocardio-
raphy (TEE) immediately before valve implantation, under
eneral anesthesia, to check aortic annulus diameters ob-
ained by TTE, to qualify the opening of aortic valve
central or eccentric) and to determine aortic valve anatomy:
istribution and localization of calcifications (symmetric or
symmetric) and number of cusps (tricuspid or bicuspid).
During the procedure, TEE was used to verify the correct
ositioning of the catheter, guidewire, and device.
ND POINT: EARLY PARAVALVULAR AR AFTER TAVI. The
ccurrence of paravalvular AR was evaluated immediately
fter the device deployment and after removal of the
atheter and guidewire. Short- and long-axis TEE views
ere used to assess AR localization and grade. The AR
rading was based on color Doppler imaging with the
eight and the width of the regurgitant jet. When several
R jets were present, AR was expressed as an overall grade.
ence, with color jet extension, AR was classified into 4
rades: absent (0), trace or mild (1/4), mild-to-moderate
2/4), moderate-to-severe (3/4), and severe (4/4). Signifi-
ant AR was defined as AR 2/4.
This evaluation of AR was performed by an echocardio-
rapher who did not attend to the TAVI procedure and who
as blinded to the initial conclusions and to the angio-
raphic evaluation of AR.
To appraise the congruence between the aortic annulus
nd the device, we defined a “cover index” expressed as a
atio of: 100  ([prosthesis diameter  TEE annulus
iameter]/prosthesis diameter).
CHOCARDIOGRAPHIC EVALUATION BEFORE DISCHARGE. In
ddition, a complete TTE was performed at discharge or 7
ays after device implantation. Aortic valve hemodynamic
tatus (AVA, mean gradient, permeability index) and AR
rading were recorded.
valuation of the device positioning. To evaluate whether
he malpositioning of the prosthesis might be a cause of
ignificant paravalvular AR or not, we have reviewed the
ositioning of the device by echocardiography and fluoros-
opy in the patients with AR 2. The re-reading was
erformed retrospectively by 2 echocardiographers experi-
nced in monitoring the procedure and interventional car-
iologists who were blind to each other.
tatistical analysis. Data were expressed as mean  SD or
ercent. Comparisons of clinical, echocardiographic, or
rocedure-related characteristics of patients according to
R 2 or 2 used t test or chi-square as appropriate. Four
ignificant variables in univariate analysis (age, sex, cover
ndex, early vs. late period) were included in a multivariate
ogistic regression with a backward selection of independent
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823ariables, with a significant level of p 0.05. Adjusted odds
atio is presented with 95% confidence interval.
Comparisons of patients’ characteristics between the 2
ime-frame periods of the study used t test or chi-square as
ppropriate.
A p value 0.05 was considered statistically significant.
esults
aseline characteristics. All 74 patients (median age: 82 
years, men: 38 [51%]) had severe aortic stenosis: median
alue for AVA was 0.67  0.2 cm2 and for mean gradient
as 50  15 mm Hg (Table 1). Large range of ejection
raction was observed from 14% to 81% (mean ejection
raction 51  17%). The TAVI used transfemoral access in
6 patients and transapical access in 28 patients. Overall, 50
atients (66%) received a 26-mm prosthesis, and 24 patients
34%) received a 23-mm prosthesis.
arly AR after TAVI: frequency. Assessment of paravalvular
R showed the absence of AR in 5 patients (7%), trivial or
ild AR (1/4) in 53 patients (72%), mild-to-moderate (2/4)
n 12 patients (16%), and moderate-to-severe (3/4) in 4
atients (5%). No severe AR (4/4) was observed. Thus
ignificant AR (2/4) occurred in 16 patients (22%) im-
ediately after TAVI. The outcome of these 16 patients is
etailed in Figure 1. At the end of the procedure, balloon
e-dilation was performed in the 4 patients with AR 3/4 and
n 1 patient with AR 2/4 (Fig. 1). After re-dilation AR
Table 1. Clinical, Echocardiographic, and Procedure Characteristics of Pat
Immediately After TAVI
Variables
Overall
(n  74)
P
Clinical characteristics
Age, yrs 82 8
Sex (men) 38 (51%)
Weight, kg 69 5
Height, cm 163 8
BSA, m2 1.7 0.2
Echocardiographic characteristics
TTE systolic aortic annulus, mm 22.9 1.6
TEE systolic aortic annulus, mm 23.3 1.7
Ejection fraction, % 51 17
Aortic valve area, cm2 0.67 0.2
Aortic valve mean gradient, mm Hg 50 15
Asymmetric AV calciﬁcations 16 (35%)
Eccentric AV opening 10 (16%)
Procedure
Implantation access (femoral) 46 (62%)
Prosthesis size (26 mm) 50 (66%)
Cover index*, % 6.7 4
Values are mean SD or n (%). *Cover index defined as 100 ([prosthesis diameter – TEE annulus
AR aortic regurgitation; AV aortic valve; BSA body surface area; TAVI transcatheter aortecreased in 1 patient, remained unchanged in 3 patients, 0nd increased in 1 patient. For the latter, the balloon
nflation caused severe transvalvular AR, which required
mergent implantation of a second prosthesis. A second
rosthesis was also implanted in a patient with initial AR
/4 but did not result in a decrease in the degree of AR (Fig.
). Of note, in patients with AR 3/4, there was no particular
ndersizing of the prosthesis.
Two patients died during the first week. The causes of
eath were pulmonary infection in 1 case (immediate AR:
/4) and heart failure in the second case (immediate AR:
/4). Evaluation of AR after 7 days was available for all 72
urviving patients and showed a slight decrease in AR
rading from 2/4 to 1/4 in 3 patients and from 1/4 to 0/4 in
patients (Fig. 2). At day 7, significant paravalvular AR was
resent in 10 patients (14%). In 1 patient, significant
aravalvular AR caused refractory heart failure, and because
his patient was considered inoperable after multidisci-
linary evaluation, re-direction toward surgery was not
ade.
linical and echocardiographic determinants of paravalvular
R. The occurrence of paravalvular AR 2/4 immediately
fter valve implantation was related to older age, male sex,
nd greater height but not to larger body surface area or
eight (Table 1).
The AR 2/4 was—with regard to echocardiographic
haracteristics—significantly associated with larger aortic
nnulus dimensions, as measured by TTE or TEE (p 
Undergoing TAVI, According to Occurrence of at Least Moderate AR,
lvular AR <2/4
(n  58)
Paravalvular AR >2/4
(n  16) p Value
81 8 86 5 0.03
25 (43%) 13 (81%) 0.005
68 14 74 18 0.20
161 9 170 6 0.007
1.7 0.2 1.8 0.2 0.19
22.5 1.7 24 1 0.001
23 1.9 24.7 1.2 0.002
49 17 56 18 0.13
0.65 0.2 0.71 0.2 0.25
51 15 47 13 0.18
14 (38%) 2 (22%) 0.36
8 (17%) 2 (14%) 0.36
34 (59%) 12 (75%) 0.23
37 (64%) 13 (81%) 0.19
7.6 5 3.2 3 0.002
er]/prosthesis diameter).
implantation; TEE transesophageal echocardiography; TTE transthoracic echocardiography.ients
arava
diamet.002) (Table 1, Figs. 3 and 4). No relation to ejection
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824raction, severity of baseline aortic stenosis, eccentric aortic
alve opening, or asymmetry of aortic valve calcification was
bserved. As shown in Figures 3 and 4, AR 2/4 was never
bserved in patients with TTE or TEE aortic annulus22 mm.
The AR 2/4 after prosthesis implantation was signifi-
antly associated with a lower cover index (p  0.002). As
hown in Figure 5, AR of at least moderate degree was never
bserved in patients with a cover index 8%.
ole of procedure in occurrence of AR. The AR 2/4 was
ot associated with the type of access, femoral or apical (p
.23), (Table 1). The AR 2/4 occurred more frequently in
he first 20 procedures than in the second time-frame period
after January 9, 2008) (p  0.02), (Table 2). As shown in
able 2, this difference was not related to differences in age,
ex, height, or annulus size between the 2 periods.
eterminants of paravalvular AR in multivariate analysis. In
ultivariate analysis, the 2 independent predictors of occur-
ence of AR 2/4 were low cover index (adjusted odds ratio:
.22; 95% confidence interval: 1.03 to 1.51 per 1% decrease,
 0.02) and early versus late period of the study (adjusted
dds ratio: 2.24; 95% confidence interval: 1.07 to 5.22, p 
.03).
valuation of the device positioning. Evaluation of the
evice positioning showed an overall good agreement of the
ubjective positioning of the prosthesis between echocardio-
raphers and interventional cardiologists. The device was in
too-low position in 2 patients who received a second
AR: 4/4
AR: 3/4
AR: 2/4
AR: 1/4
Immediately 
after TAVI
After 
re-dilatati
2n
Figure 1. AR Evaluation in the 16 Patients With AR >2/4
Assessment of aortic regurgitation (AR) grade in the 16 patients with paravalv
dilation (if performed), at the end of the procedure after potential second pro
left. Solid lines indicate evolution of AR in patients undergoing balloon re-dil
prosthesis. Dotted lines represent evolution of AR in patients who did not un
patient died 4 days after TAVI); TAVI  transcatheter aortic valve implantationrosthesis (Fig. 1). This malpositioning probably contrib-ted to the occurrence of paravalvular AR. In the other
atients, the prosthesis was found in a good position.
iscussion
his study shows that significant paravalvular AR might
ccur after TAVI. The results suggest that the occurrence of
ignificant AR is related to the lack of congruence between
he annulus and the device and to the experience of the
perators.
3/4 AR
2/4 AR
1/4 AR
No AR
Immediately
after TAVI
End of 
procedure
After 7 days
14
8
2
48
5 5
53
12
12
4 2
55
Figure 2. Assessment of AR in the Study Population
Evaluation of paravalvular AR in 4 grades, immediately after valve implanta-
tion (left), at the end of the procedure after potential re-dilation or second
prosthesis implantation (middle), and at 7 days (right). Number of patients
End of 
Procedure
7 days after 
TAVI
thesis
hesis Death D4
2/4, immediately after valve implantation (on the left), after balloon re-
implantation and at 7 days (on the right). Grade of AR are indicated on the
Double solid lines indicate evolution of AR after implantation of a second
balloon re-dilation or implantation of a second prosthesis. D4  day 4 (thison
d pros
2nd prost
ular AR
sthesis
ation.
dergoin each grade is indicated on each bar. Abbreviations as in Figure 1.
A
a
A
r
w
q
r
h
c
t
a
r
v
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 2 , N O . 9 , 2 0 0 9 Détaint et al.
S E P T E M B E R 2 0 0 9 : 8 2 1 – 7 Aortic Regurgitation After Valve Implantation
825R with TAVI. On the basis of TEE performed immediately
fter the device implantation, the occurrence of paravalvular
R was frequent, as previously described (2,20), and
eached 93% of cases. In the majority of cases (77%), AR
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P=0.001
Figure 3. TTE Aortic Annulus Dimensions in Patients With AR <2/4
and >2/4
Scatter plots aortic annulus dimension measured with transthoracic echo-
cardiography (TTE) stratiﬁed according to paravalvular aortic regurgitation
(AR) classiﬁed as mild or less (AR 2/4) and at least of moderate degree
(AR 2/4). The mean and SD are represented by the bars in each groups.
The dotted line indicates the value of aortic annulus (22 mm) under which
signiﬁcant AR is never observed.
18
19
20
21
22
23
24
25
26
27
T
E
E
 A
o
rt
ic
A
n
n
u
lu
s,
 m
m
AR <2/4 AR ≥2/4
P=0.002
Figure 4. TEE Aortic Annulus Dimensions in Patients With AR <2/4
and >2/4
Scatter plots aortic annulus dimension measured with transesophageal
echocardiography (TEE) stratiﬁed according to paravalvular aortic regurgita-
tion (AR) classiﬁed as mild or less (AR 2/4) and at least of moderate
degree (AR 2/4). The mean and SD are represented by the bars in each
groups. The dotted line indicates the value of aortic annulus (22 mm)
under which signiﬁcant AR is never observed.as mild (2/4), which is likely to have limited conse-
uences, especially in the elderly population. The occur-
ence of minor leaks with no hemodynamic consequences
as been also described after surgical implantation of me-
hanical and biological prostheses (21–23). Trivial parapros-
hetic regurgitations are generally associated with a favor-
ble outcome (22,23). However, more severe paraprosthetic
egurgitations might cause hemodynamic deterioration, left
entricular remodeling, or hemolytic anemia or require
0 2 4 6 8 10 12 14 16 18
25%
20%
15%
5%
10%
0 2 4 8 16 1801 21 416
AR <2/4
AR ≥2/4
Figure 5. Distribution of Prosthesis-Annulus Cover Index
Distribution of prosthesis-annulus cover index deﬁned as 100  ([prosthe-
sis diameter  TEE annulus diameter]/prosthesis diameter). Bar height rep-
resents the number of patients. Solid bars indicate patients with AR 2/4,
and open bars indicate patients with AR 2/4. As shown with the dotted
line, AR 2/4 was never observed in patients with cover index 8%.
Abbreviations as in Figure 4.
Table 2. Comparison of the Clinical, Echocardiographic, and Procedure
Characteristics of Patients Undergoing TAVI Between the 2 Time-Frame
Periods of the Study
Variables
Period 1*
(n  20)
Period 2*
(n  54) p Value
Age, yrs 85 6 82 9 0.12
Sex (men) 13 (65%) 25 (46%) 0.15
Weight, kg 66 16 71 14 0.23
Height, cm 164 11 162 8 0.52
BSA, m2 1.7 0.2 1.8 0.2 0.46
TTE systolic aortic annulus, mm 22.8 2.1 22.9 1.5 0.61
TEE systolic aortic annulus, mm 23.6 2.3 23.3 1.7 0.84
Ejection fraction, % 46 16 53 18 0.17
Aortic valve area, cm2 0.58 0.1 0.70 0.2 0.003
Aortic valve mean gradient, mm Hg 44 14 52 14 0.03
Implantation access (femoral) 14 (70%) 32 (59%) 0.40
Prosthesis size (26 mm) 14 (70%) 36 (67%) 0.79
Cover index†, % 6.6 6 6.7 5 0.92
AR 2/4 immediately after TAVI 8 (40%) 8 (15%) 0.02
Values are mean  SD or n (%). *Period 1: October 9, 2006 to January 9, 2008; and Period 2:
January 16, 2008 to December 23, 2008. †Cover index defined as 100 ([prosthesis diameter
– TEE annulus diameter]/prosthesis diameter).Abbreviations as in Table 1.
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826eintervention (22). Similarly, after TAVI, significant para-
alvular AR can occur (4,5,8,11,24,25) and might be related
o undersized prosthesis, malpositioning of the device, the
resence of heavily calcified aortic cusps of the native valve,
r a bicuspid valve (26). In this study significant AR
epresented 22% of the patients, close to what has been
reviously published (20).
In this study, the assessment of AR was performed
mmediately after prosthesis implantation to avoid bias due
o balloon re-dilation or implantation of a second valve
rosthesis. In a previous study using the same device, less
requent AR was observed at early follow-up with TTE
ssessment than after immediate post-implantation with
EE evaluation (20). This raises the hypothesis that AR
rading is susceptible to change with the timing, as previ-
usly shown after valve replacement (21,23). Differences in
echniques (TTE and TEE) of AR evaluation might also
ontribute to explain the variations observed in AR grading.
light fluctuations were similarly observed in the current
tudy when AR grading was re-evaluated after 7 days by
TE.
mpact of annulus/prosthesis discongruence. Lack of con-
ruence between prosthesis and annulus size has been
reviously described with surgical aortic valve replacement
27–29). With a valved stent, inadequate apposition of the
evice on the aortic annulus might result in different
omplications, such as severe AR or device migration (20).
he present study shows a relationship between large
nnulus size and the occurrence of significant paravalvular
R. In patients with a large annulus, the prostheses that are
urrently available might be undersized, resulting in discon-
ruence between the annulus and the device. To appraise
he congruence between annulus and device we used a cover
ndex that integrates aortic annulus diameter as well as
rosthesis diameter. The significant relationship between
ow cover index and significant AR suggests that a certain
egree of prosthesis oversizing is needed to ensure a good
dequation of the prosthesis to the aortic annulus. This
urther stresses the importance of avoiding any undersizing
f the prosthesis. Conversely, the systematic implantation of
versized prostheses might lead to aortic annulus rupture.
Other factors might be involved in the occurrence of
aravalvular AR. In this study, the comparison of 2 time-
eriods showed that AR was larger at the beginning of the
tudy than in the second time-frame period. Hence, the
requency of significant AR can be lessened with careful
chocardiographic examination of the annulus size, which
hould lead to exclude patients with borderline annulus size
nd with improvement in TAVI technique, in particular
ccurate prosthesis positioning, which plays an essential role
n success of TAVI (5).
Accurate annulus size evaluation is difficult, because no
eference method has been described. With echocardiogra-
hy, the potential oval shape of the annulus might be not aaken into account. Other techniques, including electron-
eam computed tomography or 3-dimensional echocardi-
graphy, should be evaluated to provide accurate assessment
f the aortic annulus, even if the quality of the reconstruc-
ions faces technical difficulties. A recent study suggests that
alloon sizing with intra balloon pressures might help in
nnulus size evaluation (30). In our experience, regarding
nnulus measurement, successive steps are followed for each
atient: we initially evaluate the annulus size with TTE at
aseline; then we confirmed the measurements immediately
efore the procedure with TEE, which was our reference
ethod. Comprehensive echocardiographic examinations
y trained teams are required to accurately evaluate the
nnulus dimensions and to identify optimal prosthesis sizes.
hus experience in echocardiographic evaluation and tech-
ical achievement of TAVI might influence the occurrence
f significant AR. The fact that the cover index remains an
ndependent determinant of AR even after adjustment for
xperience suggests that it is a valuable tool to appraise
nnulus and prosthesis discongruence. Its calculation in
linical practice associated with the availability of larger
rosthesis sizes in the future might contribute to improve
he outcome of patients undergoing TAVI.
tudy limitations. Conclusions of the present study were
btained with a balloon expandable prosthesis and might
ot be valid with other devices.
Accurate assessment of paravalvular AR is difficult in the
bsence of standardized methods and only relies on color
ow imaging with direct measures of the number of jets and
et size (31).
Accurate annulus size evaluation is difficult and might
equire different techniques. However, this study was not
erformed to examine the best tools for aortic annulus evalu-
tion but to demonstrate the link between annulus size mea-
ured by methods currently available and paravalvular AR.
Outcomes of grade I paravalvular AR after TAVI are still
nknown. However, in this study we choose to focus on AR
2/4, which are more prone than AR 2 to have signifi-
ant clinical consequences.
We focused on a limited number of potential predictive
actors, given the relatively few cases of significant AR.
evertheless, given the limited experience in this topic, the
dentification of the cover index and learning curve as
redictors of AR is a relevant contribution to the evaluation
f the results of TAVI.
onclusions
his study points out that the lack of congruence between
rosthesis and annulus size, as assessed by the cover index,
s a strong determinant of paravalvular AR. Thus, to
inimize significant paravalvular AR, correct prosthesis
izing is critical. This requires an accurate evaluation of
ortic annulus dimension. The identification of a rela-
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827ionship between the device-annulus discongruence and
ccurrence of significant AR can lead to significant im-
rovements. In the future, the consequences of AR occur-
ing after TAVI should be carefully evaluated, and prosthe-
is design should be further improved to limit this
omplication.
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